当前位置:首页 > 文献互助 > 互助详情

2021 ASCO. Anlotinib plus sintilimab in patients with recurrent advanced cervical cancer: A prospective, multicenter, single-arm, phase II clinical trial. Abs#5524.复制

乔垣结衣 21天前 41 20 已关闭
互助时间线

2025-03-31 09:57:11 [关闭求助]

系统关闭了求助

备注: 此文献无全文

2025-03-31 09:49:36 [发起求助]